HK1158271A1 - Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity foxo3a - Google Patents

Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity foxo3a

Info

Publication number
HK1158271A1
HK1158271A1 HK11112506.9A HK11112506A HK1158271A1 HK 1158271 A1 HK1158271 A1 HK 1158271A1 HK 11112506 A HK11112506 A HK 11112506A HK 1158271 A1 HK1158271 A1 HK 1158271A1
Authority
HK
Hong Kong
Prior art keywords
foxo3a
haplotypes
polymorphisms
longevity
predict
Prior art date
Application number
HK11112506.9A
Other languages
English (en)
Chinese (zh)
Inventor
Timothy Atchison Donlon
Bradley John Willcox
J David Curb
Original Assignee
Kuakini Medical Ct
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41669598&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1158271(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kuakini Medical Ct filed Critical Kuakini Medical Ct
Publication of HK1158271A1 publication Critical patent/HK1158271A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/125—Allele specific primer extension
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK11112506.9A 2008-08-10 2011-11-18 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity foxo3a HK1158271A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8772208P 2008-08-10 2008-08-10
PCT/US2009/053307 WO2010019519A2 (en) 2008-08-10 2009-08-10 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity

Publications (1)

Publication Number Publication Date
HK1158271A1 true HK1158271A1 (en) 2012-07-13

Family

ID=41669598

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11112506.9A HK1158271A1 (en) 2008-08-10 2011-11-18 Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity foxo3a

Country Status (10)

Country Link
US (3) US20110212447A1 (xx)
EP (1) EP2324127B1 (xx)
JP (1) JP5814119B2 (xx)
KR (2) KR20160102081A (xx)
CN (1) CN102177255B (xx)
AU (1) AU2009282172B2 (xx)
CA (1) CA2733597C (xx)
DK (1) DK2324127T3 (xx)
HK (1) HK1158271A1 (xx)
WO (1) WO2010019519A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20160102081A (ko) * 2008-08-10 2016-08-26 쿠아키니 메디컬 센터 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법
US8990135B2 (en) * 2010-06-15 2015-03-24 The Regents Of The University Of Michigan Personalized health risk assessment for critical care
CN103233001B (zh) * 2012-06-25 2016-11-02 西北农林科技大学 秦川牛FoxO1基因单核苷酸多态性分子标记的检测方法与应用
KR102017562B1 (ko) * 2013-03-13 2019-09-03 (주)아모레퍼시픽 미백 효능 물질의 스크리닝 방법
WO2017062751A1 (en) * 2015-10-08 2017-04-13 The Regents Of The University Of California Compounds and methods for promoting stress resistance
WO2018183353A1 (en) * 2017-03-27 2018-10-04 Cardax Pharma, Inc. Small molecule compounds to support healthy human aging
CN110915165B (zh) 2017-05-12 2023-05-26 麻省理工学院 用于共享私有数据的计算机实现的方法和装置
WO2019156591A1 (en) * 2018-02-12 2019-08-15 Limited Liability Company "Gero" Methods and systems for prediction of frailty background
CN111235250A (zh) * 2020-03-31 2020-06-05 中国科学院昆明动物研究所 与健康老龄相关的关键通路及其外周血dna甲基化位点标志物和应用
JP7340872B2 (ja) 2021-09-06 2023-09-08 株式会社ミヤワキ 計測装置
CN115466321B (zh) * 2022-09-23 2024-03-22 南方医科大学珠江医院 FOXO3a-DRI肽段、其药物组合物及应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7932049B2 (en) 2002-12-23 2011-04-26 University Of Massachusetts Methods of identifying longevity modulators and therapeutic methods of use thereof
WO2005004814A2 (en) 2003-07-02 2005-01-20 Elixir Pharmaceuticals, Inc. Sirt1 and genetic disorders
US20060069049A1 (en) 2003-12-29 2006-03-30 President And Fellows Of Harvard College Methods and reagents related to foxo
CA2569079A1 (en) * 2004-06-03 2005-12-15 The Johns Hopkins University Methods of screening for cell proliferation or neoplastic disorders
US7622271B2 (en) * 2004-07-26 2009-11-24 University Of Washington Identification of aging genes through large-scale analysis
US20070118398A1 (en) * 2005-11-18 2007-05-24 Flicker Technologies, Llc System and method for estimating life expectancy and providing customized advice for improving life expectancy
JP5292569B2 (ja) * 2006-11-10 2013-09-18 国立大学法人名古屋大学 抗老化転写因子活性化剤及びその利用
KR20160102081A (ko) * 2008-08-10 2016-08-26 쿠아키니 메디컬 센터 건강한 노화 및 장수를 예측하고 증진하기 위하여 ｆｏｘｏ３ａ 다형성 및 일배체형을 사용하는 방법

Also Published As

Publication number Publication date
EP2324127A2 (en) 2011-05-25
US20130295566A1 (en) 2013-11-07
CA2733597C (en) 2019-02-26
CN102177255B (zh) 2015-12-16
EP2324127B1 (en) 2015-01-21
JP2011530312A (ja) 2011-12-22
JP5814119B2 (ja) 2015-11-17
WO2010019519A3 (en) 2010-05-27
US20110212447A1 (en) 2011-09-01
KR101649541B1 (ko) 2016-08-19
CN102177255A (zh) 2011-09-07
AU2009282172A1 (en) 2010-02-18
CA2733597A1 (en) 2010-02-18
AU2009282172B2 (en) 2016-06-02
KR20110057147A (ko) 2011-05-31
US20150337383A1 (en) 2015-11-26
EP2324127A4 (en) 2012-06-13
KR20160102081A (ko) 2016-08-26
DK2324127T3 (en) 2015-04-27
WO2010019519A2 (en) 2010-02-18

Similar Documents

Publication Publication Date Title
HK1158271A1 (en) Method of using foxo3a polymorphisms and haplotypes to predict and promote healthy aging and longevity foxo3a
EP2368114A4 (en) PREDICTION AND PREVENTION OF PREECLAMPSY
IL207752A0 (en) Methods of treating inflammation
GB2460172B (en) Installation of structures in water
EP2255263A4 (en) REACHEMINER WITH TWO REFERENCE CLOCKS AND ITS ACTUATION METHOD
BRPI0920498A2 (pt) método de tratamento de uma condição em um sujeito
EP2260081A4 (en) ORGANIC NANOPIGMENTS ENCAPSULATED IN SILPETIC ACID AND METHOD OF PREPARING THEM
EP2440223A4 (en) COMPOSITIONS AND METHODS FOR INCREASING LONGEVITY AND LIFETIME IN HEALTH
EP2171096A4 (en) CARBOXYL REPAIRS-1-POLYMORPHISMS AND METHOD FOR THEIR USE
EP2349348A4 (en) COMPOSITIONS AND METHOD FOR REDUCING SIGNS FOR SKIN AGING
BRPI0916400A2 (pt) instalação de coluna ascendente e processo de colocação no lugar de uma instalação de coluna ascendente
EP2031074A4 (en) METHOD FOR VARIATION DETECTION AND KIT THEREFOR
GB2478478C (en) Composition and method for reducing demineralization of teeth
FI20080119A0 (fi) Menetelmä ja laitteisto malminetsinnän tehostamiseksi
HUE043173T2 (hu) Eljárás és kompozíció aszpirin felszívódásának javítására
EP2257516A4 (en) METHOD FOR THE PRODUCTION OF CYCLODODECATRIOS AND METHOD FOR THE PRODUCTION OF LAUROLACTONE
EP2370091A4 (en) COMPOSITIONS AND METHODS RELATED TO ME-31
EP2284145A4 (en) MIXTURE OF POLYFLUOROALCADIENES AND METHOD FOR PRODUCING THE SAME
HU0900534D0 (en) Method and kit for improvement of prognosing of heart failure
EP2499260A4 (en) HEART AGING BIOMARKERS AND METHODS OF USE
EP2284144A4 (en) POLYFLUORO-1-ALKANE AND METHOD FOR PRODUCING THE SAME
GB2466466B (en) Wear piece element and method of construction
EP2309265A4 (en) METHOD FOR ANALYZING A COMPLEX AND KIT FOR USE THEREFOR
GB0817703D0 (en) Improvements in and relating to assaying of waste
EP2208986A4 (en) METHOD FOR DETERMINING SELF-INDUCER 2